Transcriptomic Profiling Identifies an Exosomal microRNA Signature for Predicting Recurrence Following Surgery in Patients With Pancreatic Ductal Adenocarcinoma
Satoshi Nishiwada(Baylor University Medical Center), Ajay Goel(City of Hope), Suguru Yamada(Nagoya University), Masayuki Sho(Nara Medical University), In Woong Han(Samsung Medical Center), Susan Tsai(The Ohio State University Wexner Medical Center), Kota Nakamura(Nara Medical University), Joon Oh Park(Samsung Medical Center), Tsutomu Fujii(University of Toyama), Ya Cui(University of California, Irvine), Song Cheol Kim(Ulsan College), Eunsung Jun(Asan Medical Center), Daniel D. Von Hoff(Translational Genomics Research Institute), Wei Li(First Affiliated Hospital of Xi'an Jiaotong University), Fuminori Sonohara(Nagoya University), Takahiro Akahori(Nara Medical University), Yasuhiro Kodera(Nagoya Medical Center)
Cited by 28
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
|Journal of Clinical Oncology|1997|5.9k